v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Defined Benefit Plan Disclosure [Line Items]    
Research and development expenses– related parties $ (32)
Operating loss (238) (403)
Financing expenses, net:    
Fair value measurement of the IBOT options 185
Other financing expenses, net (29) (24)
Financing expenses (income), net (29) 151
Net loss $ (267) $ (252)
Loss per common stok, basic $ (0.00) $ (0.00)
Basic weighted average number of shares of common stock outstanding 1,044,074,409 999,222,964
Comprehensive loss:    
Other comprehensive income attributable to foreign currency translation $ 16 $ 9
Comprehensive loss (251) (243)
Related Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Marketing, general and administrative expenses (165) (233)
Financing expenses, net:    
Expenses related to convertible loan terms – related parties (10)
Nonrelated Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Marketing, general and administrative expenses $ (41) $ (170)